IL153824A0 - Method and kit for diagnosis of diseases - Google Patents

Method and kit for diagnosis of diseases

Info

Publication number
IL153824A0
IL153824A0 IL15382401A IL15382401A IL153824A0 IL 153824 A0 IL153824 A0 IL 153824A0 IL 15382401 A IL15382401 A IL 15382401A IL 15382401 A IL15382401 A IL 15382401A IL 153824 A0 IL153824 A0 IL 153824A0
Authority
IL
Israel
Prior art keywords
diagnosis
kit
diseases
Prior art date
Application number
IL15382401A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL153824A0 publication Critical patent/IL153824A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15382401A 2000-07-07 2001-06-13 Method and kit for diagnosis of diseases IL153824A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00114650 2000-07-07
EP00127892 2000-12-20
EP01102732 2001-02-07
PCT/GB2001/002584 WO2002004954A2 (en) 2000-07-07 2001-06-13 Early diagnosis of conformational diseases

Publications (1)

Publication Number Publication Date
IL153824A0 true IL153824A0 (en) 2003-07-31

Family

ID=27223071

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15382401A IL153824A0 (en) 2000-07-07 2001-06-13 Method and kit for diagnosis of diseases
IL153824A IL153824A (en) 2000-07-07 2003-01-07 Method for diagnosing diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153824A IL153824A (en) 2000-07-07 2003-01-07 Method for diagnosing diseases

Country Status (31)

Country Link
US (1) US7351526B2 (el)
EP (2) EP1299729B1 (el)
JP (1) JP4790966B2 (el)
KR (1) KR100764981B1 (el)
CN (1) CN1221807C (el)
AR (1) AR029583A1 (el)
AT (2) ATE426816T1 (el)
AU (2) AU2001264089B2 (el)
BG (1) BG66272B1 (el)
BR (1) BRPI0112262B8 (el)
CA (1) CA2413078C (el)
CY (1) CY1109106T1 (el)
CZ (1) CZ304365B6 (el)
DE (2) DE60121958T2 (el)
DK (2) DK1712920T3 (el)
EA (1) EA007391B1 (el)
EE (1) EE05675B1 (el)
ES (2) ES2264691T3 (el)
HK (1) HK1058065A1 (el)
HR (1) HRP20030033B1 (el)
HU (1) HU228813B1 (el)
IL (2) IL153824A0 (el)
MX (1) MXPA03000226A (el)
NO (1) NO331624B1 (el)
NZ (1) NZ523213A (el)
PL (1) PL211154B1 (el)
PT (2) PT1299729E (el)
RS (1) RS51523B (el)
SI (2) SI1299729T1 (el)
SK (1) SK287768B6 (el)
WO (1) WO2002004954A2 (el)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1373904A1 (de) * 2001-03-13 2004-01-02 Eigen, Manfred, Prof. Dr. Verfahren zur verstärkung der bildung von aggregaten aus proteinuntereinheiten
MXPA03011000A (es) 2001-05-31 2004-02-27 Arete Associates Metodo de sensor de proteinas deformadas.
US20050026165A1 (en) * 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
EP1636592B1 (en) 2003-06-19 2012-12-19 Merck Serono SA Use of prion conversion modulating agents
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
DE10328830A1 (de) * 2003-06-26 2005-01-20 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach asymmetrischer Interaktion
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases
WO2005016127A2 (en) 2003-08-13 2005-02-24 Chiron Corporation Prion-specific peptide reagents
US20060057671A1 (en) * 2004-09-10 2006-03-16 Orser Cindy S Immobilized probes and methods of detecting conformationally altered prion proteins
JP4568840B2 (ja) * 2004-12-28 2010-10-27 国立大学法人金沢大学 アルツハイマー病の検査方法
AU2006214463B2 (en) * 2005-02-15 2012-08-30 Presympto, Inc. Method for detecting misfolded proteins and prions
WO2006113915A2 (en) * 2005-04-20 2006-10-26 Board Of Regents, The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
EP1731911A1 (fr) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé utile pour la détection d'encéphalopathies
DE102005031429A1 (de) * 2005-07-04 2007-01-11 Heinrich-Heine-Universität Düsseldorf Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen
KR20080048527A (ko) 2005-09-09 2008-06-02 노파르티스 아게 프리온-특이적 펩토이드 시약
US20070281367A1 (en) 2006-05-03 2007-12-06 Applera Corporation Methods, Compositions, and Kits for Quantitating Antibodies
EP2156181B1 (en) * 2006-07-28 2015-11-04 Adlyfe, Inc. Peptide probes for diagnostics and therapeutics
WO2008030973A2 (en) * 2006-09-06 2008-03-13 The Board Of Regents Of The University Of Texas System Methods and compositions for the detection of protein folding disorders
EP2554996B1 (en) * 2007-07-20 2016-04-06 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Detection of infectious prion protein by seeded conversion of recombinant prion protein
FR2929290B1 (fr) * 2008-03-27 2010-05-07 Lfb Biotechnologies Methode de detection et/ou de titrage in vitro d'un agent transmissible non conventionnel
JP5209712B2 (ja) 2008-05-28 2013-06-12 独立行政法人農業・食品産業技術総合研究機構 Ｂｓｅ由来異常プリオン蛋白質の効率的増幅方法
WO2009145194A1 (ja) 2008-05-28 2009-12-03 独立行政法人農業・食品産業技術総合研究機構 羊スクレイピー由来異常プリオン蛋白質の効率的増幅方法
ITMI20081052A1 (it) * 2008-06-10 2009-12-11 Univ Milano Bicocca Liposomi in grado di legare efficacemente il peptide beta-amiloide
FR2935711A1 (fr) * 2008-09-05 2010-03-12 Lfb Biotechnologies Clone cellulaire stable exprimant un prion
US20130109581A1 (en) * 2009-11-04 2013-05-02 David Peretz Positively charged species as binding reagents in the separation of protein aggregates from monomers
US20160077112A1 (en) 2014-09-11 2016-03-17 Board Of Regents Of The University Of Texas System Detection of Misfolded Proteins
US10989718B2 (en) 2014-09-11 2021-04-27 Amprion, Inc. Detection of misfolded alpha synuclein protein
US10215763B2 (en) * 2010-05-18 2019-02-26 Board Of Regents Of The University Of Texas System Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
US9910049B2 (en) 2014-09-11 2018-03-06 Amprion, Inc. Detection of misfolded amyloid beta protein
IT1405762B1 (it) 2010-11-25 2014-01-24 Icgeb Proteine ricombinanti con attivita' di inattivazione selettiva di proteine bersaglio
WO2012099884A1 (en) * 2011-01-18 2012-07-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for amplification and detection of prions
FR2973114A1 (fr) 2011-03-21 2012-09-28 Ets Francais Du Sang Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc
WO2013056841A1 (en) 2011-10-19 2013-04-25 Inra (Institut National De La Recherche Agronomique) A method for diagnosing tse
WO2015160007A1 (ko) * 2014-04-17 2015-10-22 한림대학교 산학협력단 극미량 병원성 프리온 단백질 검출방법 및 장치
US10359434B2 (en) 2014-10-22 2019-07-23 Colorado State University Research Foundation In vitro detection of prions in blood
WO2016149537A1 (en) 2015-03-17 2016-09-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
EP3635393A4 (en) 2017-05-16 2021-03-10 Claudio Soto-Jara DETECTION OF MISFOLDED TAU PROTEIN
US20190353669A1 (en) * 2018-05-16 2019-11-21 Amprion, Inc. Detection of Brain Injury or Neurological Disease using Tau Protein
US11598783B1 (en) 2019-10-23 2023-03-07 Colorado State University Research Foundation In vitro detection of prions
WO2021198098A1 (en) 2020-04-03 2021-10-07 Universität Zürich Improved method of detecting biomarkers in a biological sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
US5616871A (en) * 1995-09-28 1997-04-01 Drummond Scientific Company Pipet gun assembly
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
DE934531T1 (de) 1996-10-15 2000-04-06 Imperial College Diagnose spongiformer encephalopathie
JP2003531356A (ja) * 1999-06-29 2003-10-21 マクギル ユニバーシティー プリオンタンパク質結合タンパク質及びそれらの使用
EP1238290A1 (en) * 1999-12-10 2002-09-11 Misonix Incorporated Ultrasonic horn assembly
WO2006113915A2 (en) * 2005-04-20 2006-10-26 Board Of Regents, The University Of Texas System Ultrasensitive detection of prions by automated protein misfolding cyclic amplification

Also Published As

Publication number Publication date
ATE426816T1 (de) 2009-04-15
BRPI0112262B1 (pt) 2016-08-09
US7351526B2 (en) 2008-04-01
EP1299729A2 (en) 2003-04-09
NO20030059D0 (no) 2003-01-06
SI1712920T1 (sl) 2009-10-31
BG66272B1 (bg) 2012-11-30
WO2002004954A2 (en) 2002-01-17
CZ304365B6 (cs) 2014-04-02
KR100764981B1 (ko) 2007-10-09
KR20030036257A (ko) 2003-05-09
HUP0301020A2 (hu) 2003-07-28
DK1712920T3 (da) 2009-05-11
DK1299729T3 (da) 2006-12-04
ES2322660T3 (es) 2009-06-24
SK287768B6 (sk) 2011-09-05
AR029583A1 (es) 2003-07-02
PL211154B1 (pl) 2012-04-30
BR0112262A (pt) 2003-05-20
NZ523213A (en) 2005-01-28
IL153824A (en) 2010-02-17
EE200300005A (et) 2004-08-16
AU2001264089B2 (en) 2006-03-30
CA2413078A1 (en) 2002-01-17
BG107498A (bg) 2003-11-28
CN1221807C (zh) 2005-10-05
NO331624B1 (no) 2012-02-06
EP1712920A1 (en) 2006-10-18
US20050064505A1 (en) 2005-03-24
YU101202A (sh) 2006-01-16
ATE335204T1 (de) 2006-08-15
RS51523B (sr) 2011-06-30
PT1712920E (pt) 2009-04-09
CA2413078C (en) 2010-08-03
CY1109106T1 (el) 2014-07-02
JP4790966B2 (ja) 2011-10-12
MXPA03000226A (es) 2004-05-21
PL360397A1 (en) 2004-09-06
CZ200336A3 (cs) 2003-06-18
EA200300126A1 (ru) 2003-06-26
HUP0301020A3 (en) 2010-03-29
WO2002004954A3 (en) 2002-10-24
HU228813B1 (en) 2013-05-28
ES2264691T3 (es) 2007-01-16
SI1299729T1 (sl) 2006-10-31
BRPI0112262B8 (pt) 2021-07-27
EE05675B1 (et) 2013-08-15
NO20030059L (no) 2003-03-07
HRP20030033B1 (en) 2008-04-30
CN1449497A (zh) 2003-10-15
DE60138146D1 (de) 2009-05-07
AU6408901A (en) 2002-01-21
EP1712920B1 (en) 2009-03-25
SK18582002A3 (sk) 2003-05-02
HRP20030033A2 (en) 2004-02-29
DE60121958D1 (de) 2006-09-14
EP1299729B1 (en) 2006-08-02
EA007391B1 (ru) 2006-10-27
PT1299729E (pt) 2006-10-31
HK1058065A1 (en) 2004-04-30
DE60121958T2 (de) 2007-02-01
JP2004503748A (ja) 2004-02-05

Similar Documents

Publication Publication Date Title
IL153824A0 (en) Method and kit for diagnosis of diseases
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
EP1581119A4 (en) COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS FOR INFLAMMATORY BOWEL DISEASE
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
EP1129217A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DISEASES
EP1347051A4 (en) METHOD FOR EXAMINING AN ALLERGIC DISEASE
EP1594510A4 (en) METHOD AND KIT FOR REDUCING SYMPTOMS OF DISORDERS OF THE PERIPHERAL VASCULAR SYSTEM
AU2002353777A1 (en) Saliva-based methods for preventing and assessing the risk of diseases
AU2002336999A1 (en) Model of autoimmune disease and methods for identifying agents against autoimmune disease
AU2002220257A1 (en) Methods of treatment involving human mda-7
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AU4150999A (en) Method and kit for early diagnosis of cancer
EP1284289A4 (en) METHOD OF STUDYING ALLERGIC DISEASES
GB0117870D0 (en) Method of diagnosis and kit of parts therefor
GB0008921D0 (en) Method of treatment
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
GB0023599D0 (en) Non-invasive method for determining human photodermatoogical skin-types
GB0024938D0 (en) Method of diagnosis
GB0111441D0 (en) Method and kit for the treatment of cosmetic skin conditions
GB9922482D0 (en) Method of diagnosis
AU2543301A (en) Method and kit for diagnosis of neoplastic transformation
AU2002210761A1 (en) Method of determining susceptibility to diseases
EP1303281A4 (en) METHODS OF TREATMENT
AU6026301A (en) Method and probes for the genetic diagnosis of hemochromatosis